David Ricks, Eli Lilly CEO (AP Photo/Carolyn Kaster)
IRA side effect: Pharma companies will increasingly skip Medicare altogether, Lilly CEO says
As the Centers for Medicare and Medicaid Services races to finalize guidance on how it will negotiate — or dictate, depending on if you ask a …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
